- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Fluorescent imaging agent goes to market
Fluorescent imaging agent goes to marketVPDiagnostics mints MR plaque analysis softwareZiosoft unveils subscription program
Fluorescent imaging agent goes to market
VisEn Medical, a specialist in fluorescence in vivo imaging, launched a new in vivo imaging agent for preclinical research. Following the launch of IntegriSense 680, the new agent, IntegriSense 750, is tuned to the assessment of integrin αvβ3, a biomarker closely associated with disease-related vascularity and angiogenesis. The agent was developed out of the Merck-VisEn Biomarker Imaging research collaboration to enable in vivo imaging of the biomarker's expression in order to measure and monitor aspects of disease progression and therapeutic response of disease states including oncology, cardiovascular disease, and bone disease.
VPDiagnostics mints MR plaque analysis software
Postprocessing software firm VPDiagnostics has developed a way to document carotid artery atherosclerosis MR angiograms. The tool, MRI-PlaqueView, is set to begin a multicenter clinical trial sponsored by the NIH. Cleared in December 2008, the software provides semiautomated tools, a streamlined workflow, and an optimized user interface.
Ziosoft unveils subscription program
The imaging community need not dip into its capital equipment budget for thin-client postprocessing from Ziosoft. The Japanese company has launched a monthly subscription program that allows customers to gain access to its 3D advanced visualization system, which reconstructs large image data sets acquired from CT and MR systems.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
